SCHEMBL4190691

SCHEMBL4190691

COC(=O)C=Cc1ccc(OC)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.56
FDPS P14324 2/20 0.55
KDM4E B2RXH2 5/20 0.51
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
MAPT P10636 3/20 0.51
GAA P10253 2/20 0.51
HTT P42858 2/20 0.51
JAK2 O60674 1/20 0.51
APP P05067 3/20 0.49
TTR P02766 1/20 0.49
NFE2L2 Q16236 2/20 0.48
PTPN1 P18031 1/20 0.47
HSD17B10 Q99714 3/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 2/20 0.46
MAPK1 P28482 2/20 0.46
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4190688 1.00 EPHX2 (0.56) EPHX2FDPSKDM4EALDH1A1SMN1; SMN2
SCHEMBL25940376 0.85 KDM4E (0.50) EPHX2FDPSKDM4EALDH1A1SMN1; SMN2
SCHEMBL25943492 0.84 TTR (0.48) EPHX2FDPSKDM4EALDH1A1SMN1; SMN2
SCHEMBL23134789 0.82 NFE2L2 (0.46) EPHX2FDPSKDM4EALDH1A1MAPT
SCHEMBL15210430 0.80 ALDH1A1 (0.39) KDM4EALDH1A1SMN1; SMN2GAANFE2L2
SCHEMBL20551560 0.80 P4HB (0.63) EPHX2FDPSKDM4EALDH1A1SMN1; SMN2
SCHEMBL20551559 0.80 P4HB (0.63) EPHX2FDPSKDM4EALDH1A1SMN1; SMN2
SCHEMBL66903 0.79 FDPS (0.53) EPHX2FDPSKDM4EALDH1A1SMN1; SMN2
SCHEMBL16320889 0.79 ALDH1A1 (0.54) FDPSKDM4EALDH1A1SMN1; SMN2MAPT
Methyl Cis-3,4-Dimethoxycinnamate SCHEMBL2411956 0.77 FDPS (0.80) EPHX2FDPSKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239865-A1 DIBENZYL AMINE COMPOUNDS AND DERIVATIVES PFIZER PRODUCTS INC. 2009-09-24 US disclosed
EP-1817297-A1 DIBENZYL AMINE COMPOUNDS AND DERIVATIVES Pfizer Products Inc. (US) 2007-08-15 EP disclosed
WO-2006056854-A1 DIBENZYL AMINE COMPOUNDS AND DERIVATIVES PFIZER PRODUCTS INC. (US) 2006-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239865-A1 DIBENZYL AMINE COMPOUNDS AND DERIVATIVES APOB, LDLR, CETP EPHX2 1276/4885FDPS 1247/4885KDM4E 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.